Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS

v3.24.1.u1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Total revenues $ 29,534 $ 26,070
Costs and expenses:    
Cost of product sales 2,025 977
Research and development 6,026 10,089
Selling, general and administrative 28,449 27,729
Total costs and expenses 36,500 38,795
Loss from operations (6,966) (12,725)
Interest income 593 393
Interest expense (1,874) (1,204)
Net loss $ (8,247) $ (13,536)
Net loss per share, basic (in dollars per share) $ (0.05) $ (0.08)
Net loss per share, diluted (in dollars per share) $ (0.05) $ (0.08)
Weighted average shares used in computing net loss per share, basic (in shares) 175,203 173,568
Weighted average shares used in computing net loss per share, diluted (in shares) 175,203 173,568
Product sales, net    
Total revenues $ 26,003 $ 23,745
Revenues from collaborations    
Total revenues $ 3,531 $ 2,325